{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:13:28Z","timestamp":1789398808272,"version":"build-2803163510"},"reference-count":28,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"abstract":"\n Importance<\/jats:title>\n Cesarean delivery is the most common surgery in the US and the most significant risk factor for postpartum infection. Although trial evidence demonstrated that adjunctive azithromycin use at the time of birth reduces postpartum infection in pregnant persons who undergo an unscheduled cesarean delivery, use of azithromycin outside that trial has not been reported.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To determine the adoption of trial evidence in clinical practice and describe postpartum infection trends among US pregnant persons undergoing unscheduled cesarean delivery.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n Data from Epic Cosmos were used to conduct a difference-in-differences analysis including pregnant individuals who received prenatal care, labored, and gave birth to a liveborn singleton infant at 24 to 43 weeks\u2019 gestation from 2013 to 2024. Cesarean birth was considered the treatment group and vaginal birth was considered the control group. The analysis was conducted from July 2025 to June 2026.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Relative to the publication of trial evidence in 2016, births that occurred from January 1, 2013, to September 28, 2016, were compared with births that occurred from January 1, 2017, to December 31, 2024.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcomes were perioperative administration of azithromycin and postpartum infection within 6 weeks of delivery. Patient-level linear regression was used to obtain the difference-in-differences estimate.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of the 1\u202f663\u202f441 infant deliveries included in the analysis, there were 202\u202f234 cesarean births and 1\u202f461\u202f207 vaginal births (mean age of pregnant individuals, 29.3 [SD, 5.7] years; median body mass index at time of delivery, 31.8 [IQR, 28.2-36.5]). From January 1, 2013, to September 28, 2016, azithromycin was administered during 2.2% of cesarean births (721\/32\u202f970) vs 0.01% of vaginal births (15\/261\u202f624) compared with 39.6% (67\u202f094\/169\u202f264) vs 0.04% (421\/1\u202f199\u202f583), respectively, from January 1, 2017, to December 31, 2024 (adjusted difference-in-differences estimate, 37.6 percentage points [95% CI, 33.1 to 42.2]). From January 1, 2013, to September 28, 2016, postpartum infection occurred after 9.2% of cesarean births (3048\/32\u202f970) vs 2.0% of vaginal births (5311\/261\u202f624) compared with 8.0% (13\u202f555\/169\u202f264) vs 2.7% (32\u202f581\/1\u202f199\u202f583), respectively, from January 1, 2017, to December 31, 2024 (adjusted difference-in-differences estimate, \u22122.0 percentage points [95% CI, \u22122.6 to \u22121.4]).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n After publication of the trial evidence in 2016, azithromycin use for pregnant persons undergoing unscheduled cesarean delivery increased and postpartum infection rates decreased in the US.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jama.2026.15010","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:01:21Z","timestamp":1789398081000},"source":"Crossref","is-referenced-by-count":0,"title":["Adoption of Adjunctive Azithromycin for Unscheduled Cesarean Delivery and Postpartum Infections"],"prefix":"10.1001","author":[{"given":"Taylor S.","family":"Freret","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Litman","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California\u2013San Diego, La Jolla"},{"name":"Department of Medicine, University of California\u2013San Diego, La Jolla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne-Marie","family":"Guise","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"},{"name":"Center for Learning Health Care Delivery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Little","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Clapp","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"issue":"3","key":"joi260091r2","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/AOG.0b013e318197c3b6","article-title":"Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.","volume":"113","author":"Tita","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"7","key":"joi260091r3","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1055\/a-1785-8843","article-title":"Mode of delivery and unplanned cesarean: differences in rates and indication by race, ethnicity, and sociodemographic characteristics.","volume":"41","author":"Williams","year":"2024","journal-title":"Am J Perinatol"},{"issue":"1","key":"joi260091r4","first-page":"1","article-title":"Births: final data for 2023.","volume":"1","author":"Osterman","year":"2025","journal-title":"Natl Vital Stat Rep"},{"issue":"6S","key":"joi260091r5","doi-asserted-by":"publisher","first-page":"S464","DOI":"10.1016\/j.ajog.2025.08.007","article-title":"Infection after cesarean delivery: diagnosis, pathophysiology, management, and prevention.","volume":"233","author":"Duff","year":"2026","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"joi260091r6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1471-0528.2010.02729.x","article-title":"Current debate on the use of antibiotic prophylaxis for caesarean section.","volume":"118","author":"Lamont","year":"2011","journal-title":"BJOG"},{"issue":"13","key":"joi260091r8","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1056\/NEJMoa1602044","article-title":"Adjunctive azithromycin prophylaxis for cesarean delivery.","volume":"375","author":"Tita","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"joi260091r9","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2024.2367082","article-title":"Neonatal outcomes in term and preterm infants following adjunctive azithromycin antibiotic prophylaxis for non-elective cesarean delivery.","volume":"37","author":"Martin","year":"2024","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"joi260091r10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/AOG.0000000000002129","article-title":"Economic evaluation of adjunctive azithromycin prophylaxis for cesarean delivery.","volume":"130","author":"Harper","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"3","key":"joi260091r11","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1097\/AOG.0000000000002834","article-title":"ACOG Practice Bulletin No. 199 summary: use of prophylactic antibiotics in labor and delivery.","volume":"132","author":"American College of Obstetricians and Gynecologists","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"1","key":"joi260091r12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/17453670610013367","article-title":"\u201cTo whom do the results of this trial apply?\u201d external validity of a randomized controlled trial involving 130 patients scheduled for primary total hip replacement.","volume":"78","author":"Petersen","year":"2007","journal-title":"Acta Orthop"},{"issue":"9596","key":"joi260091r14","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"joi260091r15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/EDE.0000000000001915","article-title":"Use of routinely collected data to classify planned mode of delivery among pregnancies with a previous cesarean delivery: a validation study.","volume":"37","author":"Brown","year":"2026","journal-title":"Epidemiology"},{"key":"joi260091r16","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1111\/1475-6773.12797","article-title":"Shifting patterns in cesarean delivery scheduling and timing in Oregon before and after a statewide hard stop policy.","volume":"53","author":"Muoto","year":"2018","journal-title":"Health Serv Res"},{"issue":"2","key":"joi260091r17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/AOG.0000000000005037","article-title":"Adjunctive azithromycin prophylaxis for prelabor cesarean birth.","volume":"141","author":"Ruzic","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"6S","key":"joi260091r18","doi-asserted-by":"publisher","first-page":"S524","DOI":"10.1016\/j.ajog.2025.08.008","article-title":"Surgical site infections after cesarean delivery.","volume":"233","author":"Hayasaka","year":"2026","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"joi260091r19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1600-0412.2011.01090.x","article-title":"Obesity, diabetes, and the risk of infections diagnosed in hospital and post-discharge infections after cesarean section: a prospective cohort study.","volume":"90","author":"Leth","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"joi260091r20","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jogc.2017.09.020","article-title":"Caesarean delivery surgical site infection: what are expected rates and potentially modifiable risk factors?","volume":"40","author":"Haidar","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"issue":"4","key":"joi260091r21","doi-asserted-by":"publisher","first-page":"538,e1","DOI":"10.1016\/j.ajog.2015.06.064","article-title":"Serious maternal complications after early preterm delivery (24-33 weeks\u2019 gestation).","volume":"213","author":"Reddy","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"joi260091r22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12919-023-00285-8","article-title":"Rethinking the pros and cons of randomized controlled trials and observational studies in the era of big data and advanced methods: a panel discussion.","volume":"18","author":"Fernainy","year":"2024","journal-title":"BMC Proc"},{"issue":"4","key":"joi260091r23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/14740338.2023.2203488","article-title":"There is no single gold standard study design (RCTs are not the gold standard).","volume":"22","author":"Gerstman","year":"2023","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"joi260091r24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/jwh.2019.7658","article-title":"Insurance differences in preventive care use and adverse birth outcomes among pregnant women in a Medicaid nonexpansion state: a retrospective cohort study.","volume":"29","author":"Taylor","year":"2020","journal-title":"J Womens Health (Larchmt)"},{"issue":"6","key":"joi260091r25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1017\/ice.2019.66","article-title":"Surgical site infection risk following cesarean deliveries covered by Medicaid or private insurance.","volume":"40","author":"Yi","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12 pt 2","key":"joi260091r26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.102325","article-title":"National trends in lipid levels in the United States from 2000 to 2023 using the Epic Cosmos database.","volume":"4","author":"Williams","year":"2025","journal-title":"JACC Adv"},{"issue":"1","key":"joi260091r27","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1038\/s41598-024-56486-4","article-title":"Obstetric infections and clinical characteristics of maternal sepsis: a hospital-based retrospective cohort study.","volume":"14","author":"Kvalvik","year":"2024","journal-title":"Sci Rep"},{"issue":"5","key":"joi260091r28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1365-3016.2012.01303.x","article-title":"Validity of using ICD-9-CM codes to identify selected categories of obstetric complications, procedures and co-morbidities.","volume":"26","author":"Goff","year":"2012","journal-title":"Paediatr Perinat Epidemiol"},{"key":"joi260091r1","unstructured":"US Centers for Disease Control and Prevention. Pregnancy-related deaths: data from Maternal Mortality Review Committees. Accessed March 10, 2026. https:\/\/www.cdc.gov\/maternal-mortality\/php\/data-research\/mmrc\/index.html"},{"key":"joi260091r7","unstructured":"US Centers for Disease Control and Prevention, National Center for Health Statistics. National Vital Statistics System, Natality on CDC WONDER Online Database. Accessed April 22, 2026. http:\/\/wonder.cdc.gov\/natality-expanded-current.html"},{"key":"joi260091r13","unstructured":"Epic Systems Corporation. Epic Cosmos. Accessed March 15, 2026. https:\/\/cosmos.epic.com\/"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2854049\/jama_freret_2026_oi_260091_1788550995.03506.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:01:24Z","timestamp":1789398084000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2854049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":28,"URL":"https:\/\/doi.org\/10.1001\/jama.2026.15010","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,14]]}}}